YAP1 Is a Potential Predictive Molecular Biomarker for Response to SMO Inhibitor in Medulloblastoma Cells
Gustavo Alencastro Veiga Cruzeiro(Broad Institute), Elvis Terci Valera(Society of Surgical Oncology)
Cited by 3
Related Papers
Molecular Profiling Identifies Prognostic Subgroups of Pediatric Glioblastoma and Shows Increased YB-1 Expression in Tumors
|Journal of Clinical Oncology|2007|219